Follow the Lumexa Imaging Holdings, Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.2bn. The latest transaction was reported on 12 June 2026 (Attribution). Among the most active insiders: BRODNAX BRETT. All data is free.
Analysts rate Lumexa Imaging Holdings, Inc. Strong Buy (bullish), based on 7 analysts. Average price target: US$17.29.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Lumexa Imaging Holdings, Inc. is a company listed on the XNAS market, specializing in the development of advanced imaging solutions. It focuses on technological innovation in the field of medical imaging.